شرکت گروه دارویی برکت
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Arabic
  • Persian
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Arabic
  • Persian
بدون نتیجه
مشاهده تمام نتایج
شرکت گروه دارویی برکت
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
  • Media
  • Subsidiaries
  • About Us
  • Contact Us
  • Arabic
  • Persian
صفحه اصلی Barkat News

High efficacy of Barakat vaccine in preventing death

The result of a scientific study on the effectiveness of the Barakat vaccine

bpharmed توسط bpharmed
20 فروردین 1401
در Barkat News
0 0
A A
0
0
اشتراک گذاری ها
117
بازدیدها

The study of the effectiveness of Covid 19 vaccines including Barakat, Strazenka, Sinofarm and Sputnik after the study in Isfahan province, is now available in Fars province and in the form of a pre-article.

According to the report, the effectiveness of Barakat in preventing death, hospitalization and positive test of Covid 19 was more mentioned than other vaccines, so that the effectiveness of Barakat was 87.1, 86.4 and 98.3%, respectively.

According to this article, the effectiveness of Astraznka vaccine is 84.4%, 81.5% and 91.8%, respectively, Sinofarm 79.9%, 71.9% and 86.1%, respectively, Sputnik 74.7% and 67%, respectively. It was 5 and 74.7 percent.

Also, the effective estimates for reducing the incidence of infection in the age group over 64 years, for Barakat, Strazenka, Sinofarm and Sputnik were 67%, 62.4%, 29.1% and 76.3%, respectively.

Reduction of hospitalization thanks to the blessing vaccine

The effect of reducing hospitalization in the age group over 64 years has been relatively low. For Barakat, Strazenka, Sinofarm and Sputnik are 80.3%, 76%, 45.7% and 45.5%, respectively.

According to this article, the reduction in mortality for all vaccines in all age groups is reported to be at least 95%, and only in the two age groups 18 to 44 years and also over 64 years who received Sinofarm, the effect on reducing death, respectively, 87.3 and 86.3 are reported.

Of the total population, 75.33% received cinopharm, 14.87% estrazenka, 8.18% blessing and 1.62% sputnik.

In this study, people with a previous history of Covid 19 were excluded and only those who received two doses of the vaccine (more than 881 thousand people) were studied.

The start date of vaccination and study in this project is February 11, 2017 and follow-up in the study has been done until October 20, 2014. The wrist study was performed for the age group, but it is not clear how long the follow-up is for each vaccine.

Optimal efficacy of Barakat vaccine against positive corona test

In this article, the effect against the positive test of Covid 19 has been done, the result shows that the effectiveness of the blessing vaccine is 87.1% and the confidence interval is 95%, in the Strazenka vaccine 84.4% (83.5 to 85.3). Was 79.9% (79.4 to 80.4%) for the cinopharm vaccine and 74.7% (71 to 78.4%) for the sputnik vaccine.

Regarding the effectiveness of the vaccines in reducing hospitalization, the results show that in the case of Barakat vaccine 86.4% and 95% confidence interval between (84.1 to 88.8%), in the case of Strazenka vaccine 81.5% (79%). 5 to 83.4), 71.9% (70.7 to 73.1%) was reported for Sinofarm vaccine and 67.5% (59.5 to 75.6%) for Sputnik vaccine.

According to this article, the effectiveness against death from Covid 19 is 98.3% Barakat vaccine and 95% confidence interval between 96.3 to 100, Strazenka vaccine 91.8% (88.2 to 95.4), Sinofarm vaccine 86 1.1% (84.1 to 88) and sputnik vaccine 74.7% (71 to 78.4).

According to IRNA, Barakat is a sample of Covid 19 vaccine produced by the Iranian Shafa Pharmed Industrial Group, a company affiliated with the Barakat Pharmaceutical Group, owned by Farman Imam Executive Headquarters.

Injection of Barakat vaccine after obtaining a license from the Food and Drug Administration of Iran began on May 25, 1400 in Iran

Bahram Ainollahi, Minister of Health, Treatment and Medical Education, said on Thursday, January 2, that according to scientific studies, the Kuo Barakat vaccine is one of the least complicated corona vaccines in the world.

Corona has been spreading in the country since the beginning of March 1998, and so far 132,230 of our compatriots have died due to the virus.

The national vaccination started in the country on February 13 of last year and so far 60 million 465 thousand 452 people in the first dose, 53 million 517 thousand 573 people in the second dose and 14 million 269 thousand 799 people in the third dose of Corona vaccine. The total number of vaccines injected in the country has reached 128 million 252 thousand 824 doses.

Corona casualties have been declining in recent weeks, following the fifth Corona crossing, due to the 13th government’s approach to increasing vaccine imports and maximizing vaccination.

پست قبلی

Evaluation of the neutralizing properties of Iran Koo vaccine on disturbing variants of Corona virus

پست‌ بعدی

The specific vaccine “omicron” is produced by Iranian scientists

bpharmed

bpharmed

پست‌ بعدی

The specific vaccine "omicron" is produced by Iranian scientists

دیدگاهتان را بنویسید لغو پاسخ

نشانی ایمیل شما منتشر نخواهد شد. بخش‌های موردنیاز علامت‌گذاری شده‌اند *

Latest News

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

The specific vaccine “omicron” is produced by Iranian scientists

The result of a scientific study on the effectiveness of the Barakat vaccine

“Barakat” received a license to increase its capital by 27%

Take a look at the portfolio of Barakat Pharmaceutical Group in January

Shareholders read “Barakat” (January 7) / Price drop for the third day in a row

Barkat Pharmaceutical Group is one of the largest pharmaceutical holding Companies with more than 20 subsidiaries. The company’s name was was changed to “Tadbir innovation pharmaceutical company” in 2010.

Latest News

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

بازدید مدیران گروه دارویی برکت از کارخانه شرکت سبحان آنکولوژی

14 آذر 1401
The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

The scientific article of phase one and two of Bovine Bovine vaccine was published in BMJ open journal

14 خرداد 1401

Contact Us

Address : No. 11, 5th Alley, Bucharest Ave, Argentina Sq, Tehran, Iran

Phone :  +98 21 88480161

Email : info@bpharmed.com

Email Affairs Stock : stock@bpharmed.com

Follow Us

Copyright © 2020-2022 by www.bpharmed.com All Rights Reserved
powered by ravian

  • Subsidiaries
  • About Us
  • Contact Us
بدون نتیجه
مشاهده تمام نتایج
  • Home Page
  • News
    • Barkat News
    • Company News
    • Stock News
    • Scientific Articles
  • Media
    • Photo Gallery
    • Video Archive
  • Subsidiaries
  • About Us
  • Contact Us
  • Arabic
  • Persian

Copyright © 2020-2022 by www.bpharmed.com All Rights Reserved
powered by ravian

خوش آمدید!

به حساب خود در زیر وارد شوید

رمز عبور را فراموش کرده اید؟

رمز عبور خود را بازیابی کنید

لطفا نام کاربری یا آدرس ایمیل خود را برای بازنشانی رمز عبور خود وارد کنید.

ورود به سیستم

Add New Playlist